Needham analyst Bernie McTernan has reiterated a Hold rating on AppLovin Corp. After reviewing over 2,200 ecommerce websites, McTernan's APP Ecommerce Tracker found 297 sites working with AppLovin, ...

Curevo, a Seattle-based biotech startup developing a vaccine against shingles, raised $110 million in a Series B ...

Home improvement products distributor Marwynn priced its IPO at the bottom of the range to raise $8 million at a $68 million ...

Hinge Health files for an IPO, aiming for a NYSE listing under 'HNGE' as revenue jumps 33% to $390M in 2024 and net losses narrow significantly.

Welcome to Startups Weekly — your weekly recap of everything you can’t miss from the world of startups. Want it in your inbox ...

The updates aim to fortify the confidentiality, integrity and availability of electronic protected health information, or ...

Vori Health, a virtual musculoskeletal care company, closed a $53 million Series B funding round. Venture capital firm NEA ...

After scrapping plans for an IPO in 2022, Hinge Health Inc. is taking a more favorable view of going public given the increased support seen for health care and med-tech stocks in recent months. The ...

Hinge Health files IPO with CEO Daniel Perez holding 19% voting power. Major clients include HCSC, Elevance Health & Aetna.

Hinge Health, Inc. targets a $326B market with innovative musculoskeletal care solutions. Click here to find out more about the upcoming HNGE stock IPO.

The digital health IPO market has slowed to a crawl in recent years, but it could be poised for a turnaround in 2025, experts ...

Market volatility makes listing a ‘monumental challenge.’ Meanwhile, limited partners are under pressure as distributions dry up.